IL-10 Gene Variation and Multiple Sclerosis: What a New Meta-Analysis Reveals
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system characterized by immune-mediated demyelination, axonal injury, and neurological dysfunction. Although environmental triggers, autoimmune mechanisms, and genetic susceptibility all contribute to disease development, the precise biological pathways that determine individual risk remain incompletely defined. The article by Khorasani and colleagues examines one such pathway: variation in the interleukin-10 gene, specifically the −1082 G/A polymorphism, also known as rs1800896, and its association with MS susceptibility. By using a meta-analytic approach, the authors aimed to consolidate evidence from multiple case-control studies and provide a clearer estimate of whether this immune-regulatory genetic variant is linked to MS risk.
Biological Rationale: Why IL-10 Matters in MS
Interleukin-10, or IL-10, is a major anti-inflammatory cytokine produced primarily by macrophages and T lymphocytes. Its role is especially relevant in autoimmune diseases because it can suppress excessive inflammatory responses and limit tissue damage. In MS, autoreactive immune cells attack components of central nervous system myelin, producing inflammatory lesions and disrupting neural signaling. The article emphasizes that disturbances in the balance between pro-inflammatory and anti-inflammatory cytokines may contribute to MS susceptibility. Since IL-10 can downregulate inflammatory activity, genetic variants that influence IL-10 expression may plausibly affect whether inflammatory immune responses become damaging enough to promote MS onset or progression.
The Genetic Focus: IL-10 −1082 G/A Polymorphism
The IL-10 gene is located on chromosome 1q31–32, and several promoter-region polymorphisms have been associated with differences in cytokine production. Among these, the −1082 G/A variant is particularly important because promoter polymorphisms can influence gene transcription and therefore alter the amount of IL-10 produced. The article focuses on whether this single nucleotide polymorphism is associated with genetic predisposition to MS. This is a biologically coherent question: if a variant is linked to lower or higher IL-10 production, it could theoretically shift the immune system toward either greater inflammatory activity or stronger immune regulation. In the context of MS, such a shift could influence disease risk, relapse tendency, or inflammatory recovery.
Study Design: A Meta-Analysis of Case-Control Evidence
The authors searched Google Scholar, PubMed, Scopus, and Web of Science for studies published up to 2022 that investigated the association between IL-10 −1082 G/A polymorphism and MS. They included case-control studies that reported genotype frequencies in both patient and control groups and contained enough data to calculate odds ratios with 95% confidence intervals. After screening 40 initial records, they selected six studies for the final analysis, comprising 1042 MS cases and 1299 controls. The included studies came from populations including Bulgaria, Iran, Iraq, Lithuania, and a Caucasian cohort, and they used genotyping methods such as ARMS-PCR, PCR-RFLP, sequencing, and allele-specific PCR. The flow diagram on page 3 illustrates this selection process, narrowing the literature from 40 database records to six eligible studies.
Main Findings: Evidence of Association Between IL-10 Genotype and MS
The meta-analysis evaluated the association under several genetic models, including allelic, dominant, recessive, overdominant, and pairwise genotype comparisons. The authors reported statistically significant associations in several fixed-effect models, including A versus G, AA versus AG+GG, AA+AG versus GG, AA versus GG, and AA versus AG. For example, the fixed-effect analysis for A versus G produced an odds ratio of 0.8192 with a 95% confidence interval of 0.7282–0.9216, while AA versus GG produced an odds ratio of 0.6370 with a 95% confidence interval of 0.4896–0.8288. The forest plots on pages 4 and 5 visually summarize these comparisons and show that the direction and magnitude of association varied across individual studies. Overall, the authors concluded that IL-10 −1082 G/A polymorphism is significantly associated with MS susceptibility.
Interpretation and Scientific Significance
The significance of this work lies in its attempt to clarify inconsistent findings from previous individual studies. Earlier research had not produced a definitive consensus, and the article notes that a previous meta-analysis did not identify a significant association between IL-10 −1082 polymorphism and MS. By incorporating more recent data, the authors suggest that the relationship may be stronger than previously recognized. Scientifically, this supports the broader hypothesis that immune-regulatory genes contribute to MS risk. However, the finding should be interpreted as a contribution to risk architecture rather than as a deterministic genetic marker. MS is a complex polygenic and multifactorial disease, meaning that IL-10 variation is unlikely to act alone; instead, it may interact with other genetic variants, HLA alleles, environmental exposures, infection history, vitamin D status, smoking, and broader immune regulation.
Limitations and Future Directions
Despite its value, the meta-analysis has several important limitations. The number of included studies was small, some comparisons showed substantial heterogeneity, and only the Lithuanian study was reported to be in Hardy-Weinberg equilibrium, which raises concerns about population structure, sampling, or genotyping consistency in other datasets. The authors also acknowledge that the analysis was limited to selected databases, English-language studies, and particular ethnic populations, meaning the results may not generalize globally. Future research should therefore include larger multiethnic cohorts, standardized genotyping, functional assays measuring IL-10 expression, and integration with polygenic risk score models. If validated, IL-10 −1082 G/A could become one component of a broader immunogenetic profile for MS risk stratification and may help guide research into therapies aimed at restoring anti-inflammatory balance in autoimmune neuroinflammation.
Disclaimer: This blog post is based on the provided research article and is intended for informational purposes only. It is not intended to provide medical advice. Please consult with a healthcare professional for any health concerns.
References:
Khorasani, M., Nezafati, A., Rezaei, E. et al. Interleukin 10 gene polymorphism − 1082 (rs1800896) and its effect in multiple sclerosis. Egypt J Med Hum Genet 27, 9 (2026). https://doi.org/10.1186/s43042-026-00837-5
